[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE68909501D1 - Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien. - Google Patents

Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.

Info

Publication number
DE68909501D1
DE68909501D1 DE89110821T DE68909501T DE68909501D1 DE 68909501 D1 DE68909501 D1 DE 68909501D1 DE 89110821 T DE89110821 T DE 89110821T DE 68909501 T DE68909501 T DE 68909501T DE 68909501 D1 DE68909501 D1 DE 68909501D1
Authority
DE
Germany
Prior art keywords
hydroxyalkylcystone
expectorants
derivatives
hydroxyalkylcystone derivatives
expectorants containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89110821T
Other languages
English (en)
Other versions
DE68909501T2 (de
Inventor
Yoshikuni Itoh
Hiroyuki Mizuno
Chikako Kiyohara
Susumu Sato
Tatsuhiko Katori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of DE68909501D1 publication Critical patent/DE68909501D1/de
Publication of DE68909501T2 publication Critical patent/DE68909501T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE89110821T 1988-06-16 1989-06-14 Hydroxyalkylcystein-Derivate und diese enthaltende Expectoranzien. Expired - Fee Related DE68909501T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63148653A JPH0788352B2 (ja) 1988-06-16 1988-06-16 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤

Publications (2)

Publication Number Publication Date
DE68909501D1 true DE68909501D1 (de) 1993-11-04
DE68909501T2 DE68909501T2 (de) 1994-05-05

Family

ID=15457618

Family Applications (2)

Application Number Title Priority Date Filing Date
DE89110821T Expired - Fee Related DE68909501T2 (de) 1988-06-16 1989-06-14 Hydroxyalkylcystein-Derivate und diese enthaltende Expectoranzien.
DE68915341T Expired - Lifetime DE68915341T2 (de) 1988-06-16 1989-06-14 Expektoranz, das ein Hydroxy-alkyl-cystein-Derivat enthält.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE68915341T Expired - Lifetime DE68915341T2 (de) 1988-06-16 1989-06-14 Expektoranz, das ein Hydroxy-alkyl-cystein-Derivat enthält.

Country Status (8)

Country Link
US (2) US4906665A (de)
EP (2) EP0346882B1 (de)
JP (1) JPH0788352B2 (de)
KR (2) KR950004677B1 (de)
CA (2) CA1325597C (de)
DE (2) DE68909501T2 (de)
ES (2) ES2059625T3 (de)
HK (1) HK125096A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤
JP4098850B2 (ja) 1997-07-16 2008-06-11 久光製薬株式会社 Ｓ−（３−ヒドロキシプロピル）−ｌ−システインを含有する経口用製剤
JP2000133368A (ja) 1998-10-20 2000-05-12 Yazaki Corp 防水コネクタとダミー栓の係止構造
CA2448081A1 (en) * 2001-05-25 2002-12-05 Minoru Okada Medicinal compositions
JP3805646B2 (ja) * 2001-05-25 2006-08-02 久光メディカル株式会社 医薬液剤
US20040147605A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Drug preparations
JP4490668B2 (ja) * 2003-10-23 2010-06-30 田辺三菱製薬株式会社 下痢治療薬
WO2007040188A1 (ja) * 2005-10-03 2007-04-12 Sankyo Company, Limited 杯細胞過形成抑制のための医薬組成物
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
CN102180820B (zh) * 2011-03-16 2014-03-12 四川科伦药物研究有限公司 一种制备高纯度福多司坦的纯化方法
CN103768011A (zh) * 2012-10-23 2014-05-07 天津药物研究院 福多司坦注射剂及其制备方法
CN103113273B (zh) * 2013-02-01 2014-09-10 浙江国邦药业有限公司 一种福多司坦的合成方法
CN104418779B (zh) * 2013-08-26 2017-08-08 天方药业有限公司 高纯度福多司坦的制备方法
CN104326954B (zh) * 2014-10-17 2016-03-30 宜昌东阳光长江药业股份有限公司 一种福多司坦的合成方法
CN106432021B (zh) * 2016-09-23 2018-03-27 威海迪素制药有限公司 一种福多司坦结晶的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3111M (fr) * 1963-12-02 1965-02-08 Rech S Pharma Et Scient Médicament a base de dérivé de cystéine.
US4085217A (en) * 1964-01-29 1978-04-18 L'oreal Process and cosmetic compositions for the treatment of skin and scalp
US3891749A (en) * 1969-10-07 1975-06-24 Rech Pharm Scientifiques Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
FR2187326B1 (de) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
US4005222A (en) * 1975-05-21 1977-01-25 Mead Johnson & Company Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process
ES469060A1 (es) * 1978-04-22 1979-04-01 Invest Tecnica Aplicada Procedimiento para la preparacion de nuevos derivados tio- prenilicos con actividad farmacologica
ES524820A0 (es) * 1983-08-08 1985-02-01 Vinas Lab Procedimiento para la obtencion de un nuevo derivado de carbocisteina
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤

Also Published As

Publication number Publication date
EP0346882B1 (de) 1993-09-29
KR950004677B1 (ko) 1995-05-04
ES2059625T3 (es) 1994-11-16
EP0346882A2 (de) 1989-12-20
KR900000335A (ko) 1990-01-30
EP0346882A3 (en) 1990-12-12
ES2056153T3 (es) 1994-10-01
DE68915341D1 (de) 1994-06-23
US4906665A (en) 1990-03-06
JPH023674A (ja) 1990-01-09
US5047428A (en) 1991-09-10
CA1312090C (en) 1992-12-29
DE68909501T2 (de) 1994-05-05
DE68915341T2 (de) 1995-02-16
JPH0788352B2 (ja) 1995-09-27
HK125096A (en) 1996-07-19
KR950004676B1 (ko) 1995-05-04
KR900000336A (ko) 1990-01-30
EP0346883A3 (en) 1990-10-10
CA1325597C (en) 1993-12-28
EP0346883A2 (de) 1989-12-20
EP0346883B1 (de) 1994-05-18

Similar Documents

Publication Publication Date Title
NL940006I2 (nl) 1,2-Benzuisoxazol-3-yl-en 1,2-benzisothiazol-3-yl-derivaten.
DE68923528D1 (de) Pyrazolamide und diese enthaltende Insektizide und Mitizide.
ATE101608T1 (de) Therapeutische chinuclidinderivate.
NO872155L (no) Tetrahydronaftalin- og indanderivater.
DE68912237D1 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
NO872939L (no) Tetrahydronaftalin- og indanderivater.
DE69000467D1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69001796D1 (de) Verbinder und teile.
DE3750432D1 (de) IL-1 alpha Derivate und Medikamente.
DE3869167D1 (de) Phenyltriazol-derivate und insectizid.
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
NO905485D0 (no) Benzazepin- og benzotiazepin-derivater.
DE68917047D1 (de) Schraubmechanismus und Schraubstock.
DE68926733D1 (de) Piperidin-Derivate und diese enthaltende Hypotensiva
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
DE68920299D1 (de) Dichtung und diese verwendendes medizinisches Gerät.
DE3750067D1 (de) Disazoverbindungen und diese Disazoverbindungen enthaltende Zubereitungen.
DE3672513D1 (de) 4,5,6,7-tetrahydro-2h-indazolderivate und diese enthaltende herbizide.
DE68903777D1 (de) Schreibgeraet und zusammenbauverfahren.
DE68905298D1 (de) Dichtung und diese verwendendes medizinisches geraet.
DE3680771D1 (de) Isoxazolopyridophenoxazin- und isothiazolopyridophenoxazinderivate.
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
DE68906340D1 (de) Tetrahydronaphthalin und indan-derivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee